Quanterix SR-X Ultra-Sensitive Biomarker Detection System
Quanterix has announced the commercial availability of its SR-X Ultra-Sensitive Biomarker Detection system, powered by the firm's Simoa technology. The research-use-only system lets users design assays to detect both proteins and nucleic acids directly from blood, as well as several other complex sample types. The SR-X enables measurement of nucleic acid levels, including miRNA, without using PCR. The platform is designed to detect up to six biomarkers per sample, with low volume requirements, the company said.